Mutation Analysis
Genomic DNA was obtained using standard methods. The polymerase chain reaction was used to amplify portions of the coding region of the gene as described previo~sly.'~ The following scheme of identifying mutations was followed: (1) All DNA samples were screened for common known mutations based on ethnic background by using appropriate restriction endonuclease analysis. This was done to identify the various forms of G6PD A-at nucleotides (nts) 202 (Nla III), 680(Bsr NI), 968(Nci I), and 376(Fok I), G6PD
(Mbo 11), and G6PD Seattle-(Nla 111). We screened for known mutations G6PD Union'360T, G6PD Canton'376T, and G6PD Anant'388A by allele-specific oligonucleotide hybridization (ASOH).9 Other Asian mutations were detected using restriction endonuclease analysis. The G6PD G a o h e / G a o~h o u~~~ and G6PD V i a n g~h a n~"~ mutations were detected by digests with Hha I and 258 SSCP was performed as follows: polymerase chain reaction (PCR) was initially performed in a 50-pL system for 15 cycles at 94°C for 30 seconds, 58°C for 30 seconds, and 72°C for 45 seconds. A second PCR was done in a 10-pL system for 35 cycles using 1 pL of the initial PCR product, 0.8 pL a-"P-deoxyadenosine triphosphate (dATP) (Amersham, 3,000 CUmmol), and nested primers. PCR conditions were as above. An appropriate dilution of the PCR products was made into loading buffer and 2 pL were electrophoresed on 5% neutral polyacrylamide gel containing 5% glycerol for 6 hours (25 W). (3) Sequence analysis was performed on PCR-amplified DNA until a mutation had been identified.I4 Confirmation of mutations was performed by sequencing both strands, or by restriction digest analysis. (4) The four polymorphic sites at intron 5 (Pvu II), nt 1.1 16 (Pst I), nt 1,311 (1,31 l), and intron 11 (Nla 111). which had been reported pre~iously,8.~.''.'~ were examined using appropriate endonucleases, and the site was recorded as positive (+) if it was cleaved and negative (-) if it was not.
RESULTS

New Mutations
Eight new mutations found in G6PD-deficient individuals and their proposed names are summarized in Table 3 . Six of these were point mutations (820 G + A, 910 G + T, 1,004 C + A, 1,141 T -+ C, 1,166 A -+ G, and 1,284 C + A), one of them a nonsense mutation. One case represented a six-base deletion of nucleotides 724 to 729. A splice site mutation was encountered in intron 10. All of these muta-XU ET AL tions were encountered in patients with chronic hemolytic anemia, ie, they are class l variants. Only the "G6PD Fushan""'"A mutation was found in the course of a population survey. In each of the cases in which enzyme activity had been determined, it was very low. An exception is the patient with "G6PD Georgia"'2X4A, who was a female heterozygote for the mutation.
The point mutations at nts 910 ("G6PD West Virginia"9'"T), 1,141 ("G6PD Olomouc""4'C), and 1,166 ("G6PD Praha""hh") were initially detected by band shifts on SSCP of exons 9 and 10. Sequence analysis showed the existence of the point mutations, which were confirmed by restriction digests with Avu 11, Mbo I1 and Alu I, respectively.
In each case, the mutation destroyed a restriction site. A coincidental finding in the case of "G6PD West Virginia" was a C T transition at nt 1,191. This changes an AAC to AAT, both of which code for Asn. This silent mutation appears to be rare; we have not encountered it in any other sample, despite the fact that it was detected because it produces an abnormal fragment on SSCP.
The splice site mutation ("G6PD Varnsdorf") and the deletion in exon 7 ("G6PD Stony Brook"724-72yde' ) were also detected on SSCP and the deletions identified by sequence analysis. The deletion of nts 724 to 729 also destroyed a Dde I site. The point mutation at nt 820 ("G6PD Clevewas detected by sequence analysis and confirmed by restriction digest with Sty I. "G6PD Fushan"IwA was also detected by sequence analysis and confirmed by restriction digest because the mutation creates a Bcg I site.
The nonsense mutation in which a base substitution at nt 1,284 C -+ A created a stop codon, "G6PD Georgia"12X4A, was detected by sequence analysis. We have been unable, in spite of repeated attempts, to obtain additional blood samples from this interesting patient for further studies. However, the existence of the mutation seems to be quite clear, being verified not only by sequencing both strands, but also restriction analysis using a mismatched primer (S'CCTGACCTA-CGGCAA CAGAC A3') that creates a Dru 111 site in the normal but not themutant sequence.
The splice site mutation is the first G6PD mutation that has been encountered outside of the coding sequence. It was located at the 3' acceptor splice site of intron 10 and found in a patient from the Czech Republic with HNSHA. SSCP performed on exon 1 I showed a band shift and subsequent sequencing showed a deletion of the invariant dinucleotide ag (-2, -1 ) of the 3' acceptor splice site of intron 10 (Fig  1) . The normal 3' acceptor splice site upstream of exon l 1 has the following sequence (ag consensus bold): S' tctctccctcacag AACGTGAAGCTC 3'. The mutant sequence was as follows: 5' tctctccctcacAACGTGAAGCTC 3'. The deletion of ag at the boundary between intron 10 and exon 1 l creates a Dra 111 restriction site when using primers S'ACTCCACATGGTGGCAGGCA3' and S'ATAGCCC-ACAGGTATGCAGG3' (Fig 2) . Therefore, the presence of this mutation could easily be confirmed by Dru 111 digestion of the 167 nt segment, followed by 10% polyacrylamide gel electrophoresis.
Mutation Analysis in Digerent Ethnic Groups
Greece. Twenty-four samples from Greece were initially screened for the G6PD Mediter~anean"'~ mutation by re- striction analysis (Table 4) . Nineteen of the samples were found to have this mutation. The other three samples were screened for the common G6PD A-z02N37ffi mutation. One of the samples was found to have this mutation. Sequence analysis then showed that two samples had the G6PD Ierape-
have not yet been identified. Canary Islands. Fourteen samples from male G6PD deficient Canary Islanders were initially screened for the G6PD Mediterranean563T mutation and then for the common G6PD mutation. Twelve of the samples were found to have the 3766 mutation. Seven of these proved to be G6PD second mutation at nt 542 (G6PD Santa Mariam2N542T). Thus, three different G6PD A-genotypes were represented in tra1057T m~tati0n.I~ Mutations in the remaining two samples A -202N376G ~-202A/376G and four G6PD A-202A/968c. One sample had a this population sample. The remaining two individuals had G6PD Seattlewc. The G6PD activity of the subjects with genotype was 1.63 t 0.25 U/g hemoglobin (Hb) (mean 5 1 SE); that of the subjects with G6PD , 1.03 2 0.22 U/g Hb; those of the two with G6PD Seattle-, 1.6 and 1.5 Ulg Hb; and that of G6PD Santa
Because the mutation at 968 has previously been seen only rarely,'* it was of interest to determine if these samples had similar polymorphic haplotypes. The mutations identified are summarized in Table 5 and haplotype analysis of these mutations on the Canary Island samples are summarized in Table 6 .
Czech and Slovak Republics. Thirteen samples from Czech and Slovak Republics were screened by using enzyme
~ari~376GI542T , 2.0 u/g m. For and G6PD Seattlewc. None of these mutations were found and samples were then subjected to SSCP and sequence analysis. Five mutations were found in this population, one sample had the splice site mutation which has been described above, two of them were new point mutations nt 1,166 A + G and nt 1,141 T + C, the other two were an nt 1,192 G -, A mutation previously identified as G6PD Puerto Limon"92A2' and nt 1,160 G + A (G6PD Beverly Hills/Worcester Genova1ImA). However, the mutations of the other eight samples, including the one female, were normal on SSCP analysis and are still under investigation.
South China. Twenty samples from male G6PD-deficient subjects in the Canton province of South China were ASOH to screen for mutations at nts 1,360, 1,376, and 1,388.'"~'n The remaining samples underwent sequence analysis. A new mutation C -P A was found at nt 1,004. It results in a change from Ala to Asp in codon 335. This mutation is adjacent in location to the known G6PD Chatham"x'SA mutation.
Haplotype analysis on five mutations is summarized in Table 6 .
Cork// Cell Repository. Sixteen families had the G6PD Mediterraneadh31 mutation. Eleven of these families were of Greek or Sardinian heritage and four were of unknown origin. T h e catalog numbers of these samples were the following: GM00324. GM00325, GM03165, GM03171-GM03175, GM01 163, GM01 154, GMOI 193, GM02026A. -66
For personal use only. on March 30, 2017 . by guest www.bloodjournal.org From G6PD Panama (GM00412), which has previously been shown6s22 to be an example of G6PD Mediterranean563T and one Sardinian family (GM01188) had the G6PD Seattle844c mutation. DNA from a black female thought to be G6PD A/ B(GM00120) was, indeed, found to have G6PD A(+)37ffi. The mutations of two samples, including G6PD Hektoen (GM00738), have not yet been identified.
DISCUSSION
Predominance of Mutations in Various Ethnic Groups
Our studies define the predominant mutations in certain different ethnic groups: G6PD Mediterranean563T in Greece; G6PD and G6PD A-376N968c in the Canary Islands; and G6PD Canton1376T (also knownz3 as G6PD Tai~a n -H a k k a '~~~~, A g r i g e n t~'~~~~, G i f~~~~~~ ), and G6PD Anant'388A (also knownz3 as P e t r i~h '~~~~, D h~n '~~'~, Sap- Table 5 .
poro'388A, and K a i~i n g '~~~~) in South China. The G6PD genotype appears to have a higher incidence in the Canary Islands than previously seen elsewhere.
Haplotype Analysis
Four polymorphic sites were used to analyze linkage relationships. In agreement with previous studies, G6PD always had both Pvu I1 and Pst I sites regardless of ethnic origin.2',24
It was noted previously that there was a linkage disequilibrium between mutation 871A and polymorphic site 131 1T in Asians. G6PD Jammus7IA and G6PD V i a n g~h a n~~'~, both with the same mutation, were found in different haplotypes, indicating that these mutations may have arisen ~eparately.'~ In the present study, two 871A mutations identified in Chinese patients have T at nt 1,311, as was found in G6PD Viang~han*~I~, a variant detected in a Laotian subject.
Nine of the G6PD Canton'376T mutations have a C at nt 
Nonsense Mutation
A nonsense mutation was encountered in a Filipino G6PD-deficient heterozygote. The C + A substitution at nt 1,284 generates a stop codon, resulting in premature termination of the polypeptide chain. Because nonsense mutations have not been encountered previously, it has been suggested that complete loss of G6PD would be lethal. However, the present patient was heterozygous, and this may have made possible survival with a mutation that would have been lethal in the hemizygous state.
A somewhat surprising aspect of this patient is that the mixed red blood cell G6PD activity was diminished. One would have predicted that if there were a population of cells totally lacking G6PD, that they would either not be formed at all because the precursors would not be able to proliferate, or that they would be rapidly destroyed in the circulation, leaving only those cells that arose from a precursor with a functioning normal X chromosome to be sampled in the peripheral blood. We have previously designated this mutation "G6PD Atlanta,"7 but this was inappropriate because the G6PD Atlanta designation had been used previously to refer to an unrelated variant.26 We now propose to call the new variant "G6PD Georgia." 
3' Acceptor Splice Site Mutation
A mutation in or around a splice junction is a well-recognized cause of inherited human diseases. P-thalassemia was the first example.*'^** A limited number of diseases with mutations affecting the acceptor splice site have been documented to exert a pathologic influence on the efficiency of splicing. Almost all of the mutations described in the 3' splice site in other genes, being single base substitutions at positions -1, -2, and less commonly at position 3.
The case described in this study is the first in which a mutation has been found associated with a splicing error of the G6PD gene. A novel mutation in the 3' splice site acceptor at the end of intron 10 destroys this splice junction. The conserved sequences required for correct splicing at 5' and 3' splice site, have been characterized; the dinucleotide pairs GpT and ApG invariably demark the beginning and end of the intron, r e s p e~t i v e l y .~~~~~ A deletion or substitution of these nucleotides will result in abnormal processing of mRNA. A recent model describing exon definition in mRNA splicing identified the 3' splice site as an early step necessary for efficient splicing.3' Thus, a mutation in the 3' acceptor splice site would affect exon definition, resulting in exon skipping or incorrect splicing. Usually, alterations of the 3' acceptor splice site lead to the search for an upstream or downstream cryptic splice site, and to the activation of this alternative site, a process that frequently results in frameshift and premature termination. Alternatively, the skipping of the downstream exon also occurs. A scoring system described by Shapiro and Senapathy3' has identified potential 3' splice sites, based on the frequency of each nucleotide in the normal sequence. The scores for four cryptic splice sites within the downstream exon 1 l are calculated and shown in Table 5 . Splicing at the cryptic sites of 1, 2, and 4 (Table 7) would result in the deletion of 3, 9, or 20 amino acids, respectively, whereas splicing at the cryptic site 3 would cause a frameshift, resulting in a termination codon at nt 1,377. Because of the unavailability of mRNA from this patient, we could not perform the reverse transcription PCR studies that would show the molecular fate of this mutation, but it is likely that activation of an alternative cryptic site would result in abnormal protein and a G6PD-deficient phenotype.
Deletion of Triplet Codons
The six-base deletion of nts 724 through 729 occurring in the coding region and resulting in deletion of Gly and Thr at positions 242 and 243 in the polypeptide chain represents the third example of a deletion in the G6PD gene. We have named this variant "G6PD Stony Brook".' "G6PD Sunderland", with severe G6PD deficiency and chronic hemolytic anemia, was reported as a triplet deletion in exon 2.' A larger deletion comprised of eight amino acids was recently described in G6PD Nara.' Significantly, all of the deletions that have been found to date occur in multiples of 3, resulting in a triplet codon deletion rather than a frameshift.
